Research reveals a candidate drug and biomarker to target uveal melanoma
Source: News Medical Life Science, February 2023
Findings from an international research study involving Irish and Spanish patients reveal a candidate drug and biomarker that could be used to manage uveal melanoma.
Uveal melanoma (UM) is a rare eye cancer that begins in melanocytes – the pigment-producing cells that give eyes their color and that are also found in the back of the eye.
Ireland has the one of the highest incidence rates in the world of this rare eye cancer, which is associated with risk factors such as fair complexion, pale eyes and higher risk of burning on sun exposure.